Education
About Us
Working with TipRanks
Follow Us
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
RESEARCH TOOLSreports
Total Valuation
Shin Nippon Biomedical Laboratories, Ltd. has a market cap or net worth of ¥59.62B. The enterprise value is ―.
Market Cap¥59.62B
Enterprise Value―
Share Statistics
Shin Nippon Biomedical Laboratories, Ltd. has 41,632,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,632,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shin Nippon Biomedical Laboratories, Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee18.15M
Profits Per Employee3.80M
Employee Count1,457
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Shin Nippon Biomedical Laboratories, Ltd. is ―. Shin Nippon Biomedical Laboratories, Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Shin Nippon Biomedical Laboratories, Ltd. had revenue of 26.45B and earned 5.53B in profits. Earnings per share was 132.86.
Revenue26.45B
Gross Profit14.28B
Operating Income4.16B
Pretax Income6.97B
Net Income5.53B
EBITDA8.98B
Earnings Per Share (EPS)132.86
Cash Flow
In the last 12 months, operating cash flow was 1.80B and capital expenditures 0.00, giving a free cash flow of 1.80B billion.
Operating Cash Flow1.80B
Free Cash Flow1.80B
Free Cash Flow per Share43.26
Dividends & Yields
Shin Nippon Biomedical Laboratories, Ltd. pays an annual dividend of ¥30, resulting in a dividend yield of 4.19%
Dividend Per Share¥30
Dividend Yield4.19%
Payout Ratio42.27%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.03
52-Week Price Change9.40%
50-Day Moving Average1.36K
200-Day Moving Average1.41K
Relative Strength Index (RSI)58.82
Average Volume (3m)239.63K
Important Dates
Shin Nippon Biomedical Laboratories, Ltd. upcoming earnings date is Aug 5, 2025, TBA (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
Shin Nippon Biomedical Laboratories, Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Shin Nippon Biomedical Laboratories, Ltd. has paid 1.46B in taxes.
Income Tax1.46B
Effective Tax Rate―
Enterprise Valuation
Shin Nippon Biomedical Laboratories, Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Shin Nippon Biomedical Laboratories, Ltd. has ¥11.10B in cash and marketable securities with ¥33.35B in debt, giving a net cash position of ¥22.25B billion.
Cash & Marketable Securities¥11.10B
Total Debt¥33.35B
Net Cash¥22.25B
Net Cash Per Share¥534.49
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Shin Nippon Biomedical Laboratories, Ltd. is ¥1,620.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥1,620.00
Price Target Upside13.13% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast22.55%
EPS Growth Forecast-10.96%